The significance of the coordinated signaling and balance between Nrf2 activation under hypoxia-induced ROS generation in the tumor microenvironment (TME) and its activation in a synergistic mode with the Hif-1 pathway in tumor cells shade lights on the new views on cancer therapy to combat against tumor progression and resistance to therapy [169]. This evidence concerns the gene HIF1A and neoplasm.